Angiotensin II type 2 receptor mediates programmed cell death
about
Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growthBlockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat gliomaVasoconstriction is determined by interstitial rather than circulating angiotensin IITranscriptional and translational regulation of calpain in the rat heart after myocardial infarction--effects of AT(1) and AT(2) receptor antagonists and ACE inhibitorCardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effectsAngiotensin II's antiproliferative effects mediated through AT2-receptors depend on down-regulation of SM-20Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotesExpression of angiotensin AT(1) and AT(2) receptors in adult rat cardiomyocytes after myocardial infarction. A single-cell reverse transcriptase-polymerase chain reaction studyNew competition in the realm of renin-angiotensin axis inhibition; the angiotensin II receptor antagonists in congestive heart failure.Early streptozotocin-diabetes mellitus downregulates rat kidney AT2 receptors.Recombinant adeno-associated virus-mediated human kallikrein gene therapy protects against hypertensive target organ injuries through inhibiting cell apoptosis.Angiotensin II inhibits activity of human organic anion transporter 3 through activation of protein kinase Calpha: accelerating endocytosis of the transporter.Renin-angiotensin systems and reproduction.Angiotensin receptors: molecular biology and signalling.Redox signaling, vascular function, and hypertension.The X chromosome and ovarian failure.Angiotensin-II-induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells.Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats.'ACE inhibitors are better than AT(1) receptor blockers (ARBs)' - controversies in heart failure.Evolution and pathophysiology of chronic systolic heart failure.Glucocorticoid modulates angiotensin II receptor expression patterns and protects the heart from ischemia and reperfusion injury.Apoptosis and changes in contractile protein pattern in the skeletal muscle in heart failure.Regulation of apoptosis by vasoactive peptides.Molecular mechanisms of renal allograft fibrosis.Impact of cell type and epitope tagging on heterologous expression of G protein-coupled receptor: a systematic study on angiotensin type II receptor.Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.Natural history of seminiferous tubule degeneration in Klinefelter syndrome.Foetal hypoxia increases cardiac AT(2)R expression and subsequent vulnerability to adult ischaemic injury.Angiotensin II receptors and drug discovery in cardiovascular disease.Angiotensin II Type 1 receptor antagonists in chronic heart failure.Obstructive uropathy: an important cause of chronic renal failure in children.Ligand-independent signals from angiotensin II type 2 receptor induce apoptosisAngiotensin AT2 receptors: cardiovascular hope or hype?The renin-angiotensin-aldosterone system and the eye in diabetes.Gene expression profiling associated with angiotensin II type 2 receptor-induced apoptosis in human prostate cancer cellsHeat shock protein 70 expression is associated with inhibition of renal tubule epithelial cell apoptosis during recovery from low-protein feeding.Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.Angiotensin II activates AMPK for execution of apoptosis through energy-dependent and -independent mechanismsANG II induces apoptosis of human vascular smooth muscle via extrinsic pathway involving inhibition of Akt phosphorylation and increased FasL expressionShort-term urinary flow impairment deregulates PAX2 and PCNA expression and cell survival in fetal sheep kidneys
P2860
Q24563508-BE482180-4CCF-4A9B-9F84-BBE603E364E5Q28211260-2ED04877-1A7C-43C6-B8EE-2F9E8311B4E8Q28344910-3EE31B87-57A1-4F01-B8D8-B26EB393F80DQ28346501-923C0F9F-D433-467A-8AC5-BC817A565FF1Q28505671-75B94D9B-6766-49F8-A638-9458C8109321Q28573451-74359A8F-A8AC-408E-BB36-4DF43D4869B2Q28592947-F27809C2-3F16-4E9F-8051-1F78183492DCQ30898615-9CCCE557-D079-46E7-AD04-47083A3B4360Q31989723-D5571615-CAA3-4CAB-A649-8DD6EE3F06C5Q32032127-4A056612-781C-4CD0-877E-091443256582Q33554981-07CE3C7F-23DF-404A-950C-0397815B84A0Q33593898-99E11DF2-7FD5-4A17-9B45-D50849D0C039Q33658583-5900E2C2-F31D-4843-8D00-7A30166F8070Q33687045-AD76252D-A306-4061-B284-05708931141CQ33689229-2382BE61-2B37-4417-A123-97D5BA06A8F6Q33808375-F18D6F64-E512-40F3-AC7A-56D444C4337FQ33830299-D9E0B007-2F7A-4A81-8463-03367EC82934Q33881270-807808AD-5524-4C59-BD9D-01087FC00FFEQ33999933-F2193720-9D36-4B71-90FC-BB858782BE90Q34088198-7D6D3565-C273-4A6F-8102-EDCFE782713FQ34266992-3D1F4610-3DC7-412F-9DEA-B60F5B80785FQ34285835-9D039C05-F3DB-44C0-99F9-E5E5E59D1C8BQ34369962-8DFD54CC-FDAF-423B-85F1-557D13934682Q34421501-26FF9628-463B-4B1B-B16B-5FC142161647Q34442688-A7023F27-C769-43E4-B807-5B0E017BA46EQ34448373-3B2E6F43-C80F-4F80-9C02-0B22690A1756Q34452169-24202769-F427-4696-8673-0300AEAE1140Q34485828-189A8051-2E54-4B2A-9CB5-7CD006EE9CEDQ34496676-B55C36FD-0E62-4254-B258-008CF7DDD3A0Q34628700-A437762A-71D4-4B55-859A-960A571A12DFQ34708939-325AE074-E9F0-4ECC-BD93-6B4B339F338DQ34731369-85790EC9-141E-467F-ABBA-ECB224F08FCEQ35045801-85236910-EDD8-4C3E-A77D-6BE448466C21Q35065528-DD3F5180-A2D9-4AB8-9BAF-2B055597A16CQ35127888-5C1D9ECE-5A0F-4714-8A58-E79BD7F3324AQ35239513-2389F351-3E74-4096-A682-5F03B5177D95Q35484295-A400564C-F5CB-421D-AD7D-3F450E477397Q35543598-A7A15136-11B7-4058-93D0-27EDCF2F5664Q35552931-D1D149FC-851E-439B-897C-834BB57C6127Q35765481-E9EE3680-E27C-4311-B60E-DED719F13D23
P2860
Angiotensin II type 2 receptor mediates programmed cell death
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Angiotensin II type 2 receptor mediates programmed cell death
@ast
Angiotensin II type 2 receptor mediates programmed cell death
@en
Angiotensin II type 2 receptor mediates programmed cell death
@nl
type
label
Angiotensin II type 2 receptor mediates programmed cell death
@ast
Angiotensin II type 2 receptor mediates programmed cell death
@en
Angiotensin II type 2 receptor mediates programmed cell death
@nl
prefLabel
Angiotensin II type 2 receptor mediates programmed cell death
@ast
Angiotensin II type 2 receptor mediates programmed cell death
@en
Angiotensin II type 2 receptor mediates programmed cell death
@nl
P2093
P2860
P356
P1476
Angiotensin II type 2 receptor mediates programmed cell death
@en
P2093
P2860
P304
P356
10.1073/PNAS.93.1.156
P407
P577
1996-01-09T00:00:00Z